Bain Capital Life Sciences Investors, LLC

Q4 2024 13F Holdings

  • Location
    boston, MA
  • Num holdings

    26

  • Value ($000)

    $850,097

  • Date Filed
    02/14/2025
  • Form type
    13F-HR
  • CIK
    0001703031
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

NEWAMSTERDAM PHARMA COMPANY

ORDINARY SHARES
N62509109
$275.48M
32 %

10,719,110

NUVL
NUVL

NUVALENT INC

COM
670703107
$113.29M
13 %

1,447,267

---

PHARVARIS N V

COM
N69605108
$63.33M
7 %

3,303,381

IRON
IRON

DISC MEDICINE INC

COM
254604101
$62.35M
7 %

983,500

DNTH
DNTH

DIANTHUS THERAPEUTICS INC

COM
252828108
$58.64M
7 %

2,689,707

YB4P
YB4P

SAVARA INC

COM
805111101
$44.72M
5 %

14,565,457

OLMA
OLMA

OLEMA PHARMACEUTICALS INC

COM
68062P106
$43.55M
5 %

7,470,214

---

UPSTREAM BIO INC

COM
91678A107
$37.74M
4 %

2,295,322

ANNX
ANNX

ANNEXON INC

COM
03589W102
$26.93M
3 %

5,249,069

CDTX
CDTX

CIDARA THERAPEUTICS INC

COM NEW
171757206
$18.90M
2 %

703,080

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 26